Literature DB >> 19564206

Circulating lipoprotein(a) concentrations and abdominal aortic aneurysm presence.

Hisato Takagi1, Hideaki Manabe, Norikazu Kawai, Shin-Nosuke Goto, Takuya Umemoto.   

Abstract

To summarize the present evidence for an association between circulating lipoprotein(a) [Lp(a)] and abdominal aortic aneurysm (AAA) presence. MEDLINE database was searched to identify all case-control studies that compared circulating Lp(a) concentrations between patients with AAA and subjects without AAA. For each study, data regarding Lp(a) concentrations in both the AAA and control groups were used to generate standardized mean differences (SMDs) and 95% confidence intervals (CIs). Study-specific estimates were combined using inverse variance-weighted average of logarithmic SMDs in both fixed- and random-effects models. Our search identified five case-control studies. In total, our meta-analysis included data on 982 cases with AAA and 1296 controls without AAA. Pooled analysis of the five studies demonstrated significantly higher Lp(a) concentrations in the AAA group than those in the control group in random-effect models (SMD, 0.26; 95% CI, 0.08-0.44; P=0.005). There was significant study heterogeneity of results (P=0.03) but no evidence of significant publication bias (P=0.3272). We found that circulating Lp(a) concentrations are likely higher in cases with AAA than in controls without AAA. Higher circulating Lp(a) concentrations may be associated with AAA presence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564206     DOI: 10.1510/icvts.2009.208843

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  7 in total

1.  Lipoprotein(a) and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study.

Authors:  Yasuhiko Kubota; Aaron R Folsom; Christie M Ballantyne; Weihong Tang
Journal:  Atherosclerosis       Date:  2017-11-26       Impact factor: 5.162

2.  Lp(a)/apo(a) modulate MMP-9 activation and neutrophil cytokines in vivo in inflammation to regulate leukocyte recruitment.

Authors:  Menggui Huang; Yanqing Gong; Jessica Grondolsky; Jane Hoover-Plow
Journal:  Am J Pathol       Date:  2014-03-17       Impact factor: 4.307

Review 3.  Biochemomechanics of intraluminal thrombus in abdominal aortic aneurysms.

Authors:  J S Wilson; L Virag; P Di Achille; I Karsaj; J D Humphrey
Journal:  J Biomech Eng       Date:  2013-02       Impact factor: 2.097

4.  Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma.

Authors:  Mario Uccello; Giulia Malaguarnera; Elisa M Pelligra; Antonio Biondi; Francesco Basile; Massimo Motta
Journal:  Indian J Med Paediatr Oncol       Date:  2011-04

Review 5.  Lipoprotein (a): structure, pathophysiology and clinical implications.

Authors:  Raul Cavalcante Maranhão; Priscila Oliveira Carvalho; Celia Cassaro Strunz; Fulvio Pileggi
Journal:  Arq Bras Cardiol       Date:  2014-07       Impact factor: 2.000

6.  Lipoprotein(a) levels and risk of abdominal aortic aneurysm in the Women's Health Initiative.

Authors:  Elizabeth L Chou; Mary Pettinger; Bernhard Haring; Matthew W Mell; Mark A Hlatky; Jean Wactawski-Wende; Matthew A Allison; Robert A Wild; Aladdin H Shadyab; Robert B Wallace; Linda G Snetselaar; Matthew J Eagleton; Mark F Conrad; Simin Liu
Journal:  J Vasc Surg       Date:  2020-08-31       Impact factor: 4.268

Review 7.  Novel biomarkers of abdominal aortic aneurysm disease: identifying gaps and dispelling misperceptions.

Authors:  Demetrios Moris; Eleftherios Mantonakis; Efthymios Avgerinos; Marinos Makris; Chris Bakoyiannis; Emmanuel Pikoulis; Sotirios Georgopoulos
Journal:  Biomed Res Int       Date:  2014-05-20       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.